| Literature DB >> 16929332 |
Abstract
The main goal in the treatment of obstructive atherosclerotic renovascular disease (ARVD) is to preserve or recover renal function. The ARVD kidney continues to deteriorate in 20-40% of cases despite restoration of blood flow. Holden et al. report that renal function stabilized or improved in up to 97% of patients with the use of a distal embolic protection device.Entities:
Mesh：
Year: 2006 PMID： 16929332 DOI： 10.1038/sj.ki.5001765
Source DB: PubMed Journal: Kidney Int ISSN： 0085-2538 Impact factor: 10.612